INDIANAPOLIS – Previous explorations of a link between statins, a cholesterol lowering medication, and cognitive decline have produced inconsistent results. New research reveals that the relationship between statin use and cognitive decline appears even more complex than had been thought.In a three year epidemiological study, researchers from the Indiana University School of Medicine and the Regenstrief Institute, Inc. have found an association of statin use with less cognitive decline in elderly African Americans and report that, surprisingly, the association is even stronger for those who had discontinued use than for continuous users. Their findings are published in the Nov. 6 issue of Neurology.
